1. bookVolume 22 (2014): Issue 3 (September 2014)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

A case of fatal acute intermittent porphyria: laboratory diagnosis and pathogenesis considerations / Un caz fatal de porfirie acută intermitentă: diagnostic de laborator şi consideraţii patogenice

Published Online: 08 Oct 2014
Page range: 325 - 333
Received: 23 Apr 2014
Accepted: 22 Aug 2014
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Acute intermittent porphyria (AIP) is a metabolic disease with an autosomal dominant inheritance, with porphobilinogen (PBG) deaminase as the deficient enzyme in heme biosynthetic pathway at cytosolic subcellular locations. This diagnosis must be evoked in all adults with unexplained symptoms, but some clinical features are suggestive: women with reproductive age; abdominal pain; muscle weakness; sever and prolonged hyponatremia; dark or reddish urine.

The authors present a fatal case of a 39-years old female who presented acute abdominal pain followed by severe peripheral nervous system lesions with tetraplegia. Urine analysis showed enormously increased levels of porphirins, PBG and Δ aminolevulinic acid. The diagnosis of AIP was established and even if the correct treatment (Hemine, glucose) was administrated, the patient died after 3 weeks from onset due to a septic shock.

The authors discuss the laboratory abnormalities that are found in AIP and also the pathogenesis of the acute attack of AIP as well as the mechanism of severe nervous system damage that is less understood.

In conclusion, laboratory testing must be performed early and if a diagnose of AIP is not made promptly serious consequences may follow for the patient.

Keywords

Cuvinte cheie

1. Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med. 2005;142(6):439-50. DOI: 10.7326/0003-4819-142-6-200503150-0001010.7326/0003-4819-142-6-200503150-00010Search in Google Scholar

2. Balwani M, Desnick RJ. The porphyrias: advances in diagnoses and treatment. Blood. 2012;120(23):4496-504 DOI: 10.1182/blood-2012-05-42318610.1182/blood-2012-05-423186Search in Google Scholar

3. Palmieri C, Vigushin DM, Peters TJ. Managing malignant disease in patients with porphyria. QJM. 2004;97(3):115-26. DOI: 10.1093/qjmed/hch02710.1093/qjmed/hch027Search in Google Scholar

4. Abel G, Palmer-Toy D. Heme synthesis and catabolism. In: McClatchey KD, ed. Clinical Laboratory Medicine. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins. 2002;407-17.Search in Google Scholar

5. Bonkovsky HL. Neurovisceral Porphyrias: What a hematologist needs to know. Hematology Am Soc Hematol Educ Program. 2005:24-30. DOI: 10.1182/asheducation-2005.1.2410.1182/asheducation-2005.1.24Search in Google Scholar

6. Abou-Zeid Elias, Donofrio PD. Porphyric neuropathies. In: Donofrio PD, ed. Textbook of Peripheral Neuropathy. New York, Demos Medical Publishing. 2012;289-307.Search in Google Scholar

7. Kauppinen R, Mustajki P. Prognosis of acute intermittent porphyria: occurrence of acute attacks, precipitating factors and associated disease. Medicine (Baltimore). 1992;71(1):1-13.10.1097/00005792-199201000-00001Search in Google Scholar

8. Whatley SD, Mason NG, Woolf JR, Newcombe RG, Elder GH, Badminton MN.. Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene. Clin Chem. 2009;55(7):1406-14. DOI: 10.1373/ clinchem.2008.12256410.1373/clinchem.2008.122564Search in Google Scholar

9. Tortorelli S, Kloke K, Raymond K. Chapter 15: Disorders of porphyrin metabolism. In Biochemical and Molecular Basis of Pediatric Disease. Fourth edition. Edited by DJ Dietzen, MJ Bennett, ECC Wong. AACC Press, 2010;307-24.Search in Google Scholar

10. Nuttall KL, Klee GG. Analyses of hemoglobin metabolism - porphyrins, iron, and bilirubin. In Tietz Textbook of Clinical Chemistry. Fifth edition. Edited by CA Burtis, ER Ashwood. Philadelphia, WB Saunders Company, 2001;584-607.Search in Google Scholar

11. American porphyria foundation. Porphyrins & Porphyria diagnosis. Available from: http://www.porphyriafoundation.comSearch in Google Scholar

12. Ridley A. The neuropathy of acute intermittent porphyria. Q J Med. 1969;38(151):307-33.Search in Google Scholar

13. Ventura P, Cappellini MD, Rocchi E. The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine. Intern Emerg Med. 2009 Aug;4(4):297-308. DOI: 10.1007/s11739-009-0261-410.1007/s11739-009-0261-4Search in Google Scholar

14. Mustajoki P, Nordmann Y. Early administration of Haeme arginate for acute porphyric attacks. Arch Intern Med. 1993;153(17):2004-8. DOI: 10.1001/ archinte.1993.0041017007800810.1001/archinte.153.17.2004Search in Google Scholar

15. Bottomley SS. Porphyria. in: IIth Edition Wintrobe’s clinical hematology. Edited by Greer JP, Foerster J, Lukens JN. Philadelphia Lippincott Williams Wilkins 2004;1057-87.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo